Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Jesse Lyon

Physician Assistant Gilbert, AZ Physician Assistant

NPI 1013431188 CMS profile 10728607

3489 S Mercy Rd Ste 101, Gilbert, AZ 85297

Open in the dashboard

General payments

$28,055

315 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Jesse Lyon of Gilbert, AZ is reported in the CMS Open Payments database as having received $28,055 across 315 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $2,858 30
2024 General $15,132 21
2023 General $6,068 63
2022 General $2,074 95
2021 General $1,923 106

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jesse Lyon
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Jesse Lyon were reported at $2,858. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Jesse Lyon Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $1,923 $132 $37–$438 $132
2022 $2,074 $155 $48–$522 $149
2023 $6,068 $167 $52–$557 $160
2024 $15,132 $178 $55–$600 $164
2025 $2,858 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Corcept Therapeutics $14,794 40 payments
  2. Xeris Pharmaceuticals, Inc. $8,677 40 payments
  3. Novo Nordisk Inc $596 21 payments
  4. Insulet Corporation $549 21 payments
  5. Abbott Laboratories $399 26 payments
  6. Boehringer Ingelheim Pharmaceuticals, Inc. $387 28 payments
  7. AstraZeneca Pharmaceuticals LP $249 14 payments
  8. Lilly USA, LLC $242 13 payments
  9. AbbVie, Inc. $177 10 payments
  10. Horizon Therapeutics plc $153 6 payments
  11. Other $1,832 96 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Consulting Fee $15,825 4 payments
  2. Food and Beverage $7,696 292 payments
  3. Travel and Lodging $2,716 16 payments
  4. Honoraria $1,794 2 payments
  5. Education $24 1 payment
Products named General payments · program years 2021–2025
  1. Korlym $14,794 40 payments
  2. RECORLEV $7,919 31 payments
  3. GVOKE HYPOPEN $681 4 payments
  4. Omnipod $549 21 payments
  5. JARDIANCE $387 28 payments
  6. RYBELSUS $375 15 payments
  7. FARXIGA $249 14 payments
  8. Ozempic $246 14 payments
  9. FreeStyle Libre 3 $161 2 payments
  10. TEPEZZA $153 6 payments
  11. Other $3,608 196 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

315 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in Arizona

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record